Cargando…

Factors Associated with Non-Adherence for Prescribed Treatment in 201 Patients with Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in Anhui Province, China

BACKGROUND: This study aimed to investigate the factors associated with non-adherence of prescribed treatment in patients with multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in Anhui Province, China. MATERIAL/METHODS: A cross-sectional survey was conducted in each designated h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Qing-Qing, Wang, Jie, Sam, Napoleon Bellua, Luo, Jie, Liu, Jie, Pan, Hai-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034655/ https://www.ncbi.nlm.nih.gov/pubmed/35437301 http://dx.doi.org/10.12659/MSM.935334

Ejemplares similares

Determining Mycobacterium tuberculosis Drug Resistance and Risk Factors for Multidrug-Resistant Tuberculosis in Sputum Smear-Positive Tuberculosis Outpatients in Anhui Province, China, 2015–2016
por: Yao, Song, et al.
Publicado: (2020)

Salt reduction behavior of adults in Anhui province in 2019: a cross-sectional survey of 3,378 participants
por: Xing, Xiu-Ya, et al.
Publicado: (2023)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Epidemiological characteristics of pulmonary tuberculosis in Anhui Province, Eastern China from 2013 to 2018
por: Zhu, Qing-Qing, et al.
Publicado: (2020)

Epidemic Characteristics of HIV Drug Resistance in Hefei, Anhui Province
por: Zheng, Shan, et al.
Publicado: (2022)

Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China
por: Zhao, Bing, et al.
Publicado: (2022)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
por: Tembo, Blackson Pitolo, et al.
Publicado: (2019)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
por: Shi, Jie, et al.
Publicado: (2020)

Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
por: Chen, Ling, et al.
Publicado: (2021)

Antimicrobial Resistance and Cytotoxicity of Citrobacter spp. in Maanshan Anhui Province, China
por: Liu, Liyun, et al.
Publicado: (2017)

Successful Treatment of a Multidrug-Resistant Tuberculosis Patient with a Negative Xpert MTB/RIF Test for Rifampicin-Resistant Tuberculosis in Guizhou Province of China: A Case Report
por: Zhao, Zhao-Liang, et al.
Publicado: (2020)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China
por: Zhou, Wenjing, et al.
Publicado: (2012)

Epidemiological characteristics of multidrug-resistant Acinetobacter baumannii ST369 in Anhui, China
por: Huang, Yi, et al.
Publicado: (2023)

Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
por: Gomathi, N.S., et al.
Publicado: (2020)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China
por: Shen, Yuelan, et al.
Publicado: (2014)

Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
por: Choi, Hongjo, et al.
Publicado: (2023)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
por: Ragonnet, Romain, et al.
Publicado: (2017)

Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
por: Machado, Diana, et al.
Publicado: (2018)

Rifampicin-Resistant Multidrug-Resistant Tuberculosis Cases in Selected Hospitals in Western Oromia, Ethiopia: Cross-Sectional Retrospective Study
por: Zewdie, Olifan, et al.
Publicado: (2020)

Persistently high prevalence of primary resistance and multidrug resistance of tuberculosis in Heilongjiang Province, China
por: Li, Di, et al.
Publicado: (2016)

Evaluation of the effects of comprehensive reform on primary healthcare institutions in Anhui Province
por: Liu, Qing, et al.
Publicado: (2014)

The malaria transmission in Anhui province China
por: Kamana, Eric, et al.
Publicado: (2022)

Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa
por: Loveday, Marian, et al.
Publicado: (2020)

Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study
por: Tesfamariam, Sirak, et al.
Publicado: (2021)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Occurrence of cavernicolous ground beetles in Anhui Province, eastern China (Coleoptera, Carabidae, Trechinae)
por: Fang, Jie, et al.
Publicado: (2016)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Chylothorax in a child with rifampicin-resistant tuberculosis
por: McLaren, B, et al.
Publicado: (2019)

Navigating a Path to Rifampicin Resistance in Tuberculosis
por: Agarwal, Sakshi, et al.
Publicado: (2023)

Epidemiological characteristics an outbreak of ST11 multidrug-resistant and hypervirulent Klebsiella pneumoniae in Anhui, China
por: He, Zhien, et al.
Publicado: (2022)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2019)

Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China
por: Lu, Zhenhui, et al.
Publicado: (2019)

Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients
por: Araia, Zenawi Zeramariam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hjraa0cfrrm9m3u4hi97mlkbkk